281 related articles for article (PubMed ID: 29052707)
1. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.
Brown JM; Robinson-Cohen C; Luque-Fernandez MA; Allison MA; Baudrand R; Ix JH; Kestenbaum B; de Boer IH; Vaidya A
Ann Intern Med; 2017 Nov; 167(9):630-641. PubMed ID: 29052707
[TBL] [Abstract][Full Text] [Related]
2. Continuum of Renin-Independent Aldosteronism in Normotension.
Baudrand R; Guarda FJ; Fardella C; Hundemer G; Brown J; Williams G; Vaidya A
Hypertension; 2017 May; 69(5):950-956. PubMed ID: 28289182
[TBL] [Abstract][Full Text] [Related]
3. Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
Hundemer GL; Baudrand R; Brown JM; Curhan G; Williams GH; Vaidya A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1835-1843. PubMed ID: 28323995
[TBL] [Abstract][Full Text] [Related]
4. The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
Brown JM; Siddiqui M; Calhoun DA; Carey RM; Hopkins PN; Williams GH; Vaidya A
Ann Intern Med; 2020 Jul; 173(1):10-20. PubMed ID: 32449886
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
[TBL] [Abstract][Full Text] [Related]
6. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
7. Association of Reversal of Renin Suppression With Long-Term Renal Outcome in Medically Treated Primary Aldosteronism.
Katsuragawa S; Goto A; Shinoda S; Inoue K; Nakai K; Saito J; Nishikawa T; Tsurutani Y
Hypertension; 2023 Sep; 80(9):1909-1920. PubMed ID: 37449450
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
Hundemer GL; Agharazii M; Madore F; Vaidya A; Brown JM; Leung AA; Kline GA; Larose E; Piché ME; Crean AM; Shaw JLV; Ramsay T; Hametner B; Wassertheurer S; Sood MM; Hiremath S; Ruzicka M; Goupil R
Circulation; 2024 Jan; 149(2):124-134. PubMed ID: 38031887
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
10. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.
Ignatowska-Switalska H; Chodakowska J; Januszewicz W; Feltynowski T; Adamczyk M; Lewandowski J
J Hum Hypertens; 1997 Jun; 11(6):373-8. PubMed ID: 9249232
[TBL] [Abstract][Full Text] [Related]
12. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):51-59. PubMed ID: 29129576
[TBL] [Abstract][Full Text] [Related]
13. Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in hypertensive patients with primary aldosteronism.
Demirtas D; Sumbul HE; Bulut A; Demirtas AO; Gulumsek E; Koca H; Icen YK; Koc M
Clin Exp Hypertens; 2020; 42(1):93-98. PubMed ID: 31204516
[No Abstract] [Full Text] [Related]
14. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
Grotevendt A; Wallaschofski H; Reincke M; Adolf C; Quinkler M; Nauck M; Hoffmann W; Rettig R; Hannemann A
Endocrine; 2017 Aug; 57(2):298-307. PubMed ID: 28638984
[TBL] [Abstract][Full Text] [Related]
15. A case of normotensive primary aldosteronism--comparison with 13 previously experienced cases with hypertension.
Nishimiya T; Kikuchi K; Oimatsu H; Ota S; Nakamura Y; Shimamoto K; Iimura O
Endocrinol Jpn; 1984 Apr; 31(2):159-64. PubMed ID: 6378608
[TBL] [Abstract][Full Text] [Related]
16. Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism.
Ikemoto M; Morimoto S; Ichihara A
Hypertens Res; 2024 Jun; 47(6):1707-1718. PubMed ID: 38548912
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
19. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study.
Brown JM; Wijkman MO; Claggett BL; Shah AM; Ballantyne CM; Coresh J; Grams ME; Wang Z; Yu B; Boerwinkle E; Vaidya A; Solomon SD
Hypertension; 2022 Sep; 79(9):1984-1993. PubMed ID: 35582954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
